Koyfin Home > Directory > Health Care > Amicus Therapeutics > Return on Capital %

Amicus Therapeutics Return on Capital % Chart (FOLD)

Amicus Therapeutics annual/quarterly Return on Capital % from 2007 to 2018.
  • Amicus Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -53.00 a 52.45% decrease of -27.80 year over year
  • Amicus Therapeutics Return on Capital % for the last 12 months ending September 09, 2018 was -29.92 a 18.10% decrease of -5.42 year over year
  • Amicus Therapeutics Annual Return on Capital % for 2017 was -25.54 a 5.27% decrease of -1.35 from 2016
  • Amicus Therapeutics Annual Return on Capital % for 2016 was -24.20 a -23.80% increase of 5.76 from 2015
  • Amicus Therapeutics Annual Return on Capital % for 2015 was -29.96 a -45.63% increase of 13.67 from 2014
Other Margins & Efficiency Metrics:
  • Amicus Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-208m a 36.06% decrease of -75m year over year
  • Amicus Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -130.88 a 44.52% decrease of -58.28 year over year
View Chart On Koyfin

Quarterly FOLD Return on Capital % Data

09/2018-53.00
06/2018-16.42
03/2018-22.84
12/2017-25.20
09/2017-22.84
06/2017-25.74
03/2017-24.14
12/2016-29.63
09/2016-26.52
06/2016-25.58

Annual FOLD Return on Capital % Data

2017-25.54
2016-24.20
2015-29.96
2014-43.62
2013-59.74
2012-65.80
2011-64.20
2010-48.81
2009-4.92
2008-30.82